Trial
NCT03119701
Efficacy and Safety of FP-1201-lyo (Interferon Beta-1a) in Prevention of Multi-Organ Failure on Patients After Open Surgery for a RAAA
Phase IITERMINATEDSAFETYConfidence: MEDIUM
Sponsor
Faron Pharmaceuticals Ltd
Collaborators
—
Condition
Preventive Medicine
Intervention
Interferon Beta-1A
Why stopped
IDMC recommendation. Unexpectedly high use of concomitant corticosteroid treatment.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2021-01-14